HendersonLMKatzJBEricksonGA: 1990, In vivo and in vitro genetic recombination between conventional and gene deleted vaccine strains of pseudorabies virus. Am J Vet Res51:1656–1662.
2.
KatzJB: 1990, A dual dominant selection, dual marker gene amplification model for environmental surveillance of recombinant viral vaccines. Res Virol141:591–596.
3.
KatzJBHendersonLMEricksonGA: 1990, Recombination in vivo of pseudorabies vaccine strains to produce new virus strains. Vaccine8:286–288.
4.
KatzJBMiddleLA: 1990, Evaluation of thymidine kinase and neomycin phosphotransferase II positive selection systems for recovery of genetically atypical and recombinant DNA vaccine viruses. Biologicals18:301–304.
5.
KitS: 1990, Genetically engineered vaccines for control of Aujeszky's disease (pseudorabies). Vaccine8:420–424.
6.
KitSSheppardMIchimuraH: 1987, Second generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes. Am J Vet Res48:780–793.
7.
MellencampMWPfeifferNESuitorBT: 1989, Identification of pseudorabies virus-exposed swine with a gI glycoprotein enzyme-linked immunosorbent assay. J Clin Microbiol27:2208–2213.
8.
MettenleiterTCSchreursCThielHJ: 1987, Variability of pseudorabies virus glycoprotein I expression. Virology158: 141–146.
9.
PetrovskisEATimminsJGGiermanTM: 1986, Deletions in vaccine strains of pseudorabies virus and their effect on synthesis of glycoprotein gp63. J Virol60:1166–1169.
10.
WardleyRCThomsenDRBerlinskiPJ,: 1991, Immune responses in pigs to Aujeszky's disease viruses defective in glycoprotein gI or gX. Res Vet Sci50: 178–184.
11.
WhetstoneCMillerJBortnerD: 1989, Changes in the restriction endonuclease patterns of four modified-live infectious bovine rhinotracheitis virus (IBRV) vaccines after one passage in host animal. Vaccine7:527–532.